Search for: "Teva Pharmaceuticals"
Results 481 - 500
of 1,423
Sorted by Relevance
|
Sort by Date
8 Oct 2020, 9:59 pm
What Quantum of Culpable Conduct Is Required for an ANDA Applicant to Induce Infringement? [read post]
17 Feb 2010, 8:00 am
Teva Parenteral Medicines Inc., Teva Pharmaceuticals USA Inc. and Teva Pharmaceutical Industries Ltd. [read post]
28 Jul 2008, 7:01 pm
REDDY’S LABORATORY and TEVA PHARMACEUTICALS (Fed. [read post]
24 Feb 2015, 3:56 pm
Grant-Vacate-Remand, hence GVR (read a blurb on the decision and GVR at the Patently-O blog here).The Federal Circuit must now reconsider this case in light of the Supreme Court’s recent Teva Pharmaceuticals decision, which raised the standard for appellate review of district court factual determinations in patent claim construction rulings.Previously, the Court of Appeals for the Federal Circuit used a “de novo” standard, which meant it could take a fresh look at… [read post]
21 Oct 2019, 10:41 am
., AmerisourceBergen, Cardinal Health and Teva Pharmaceuticals on Monday morning. [read post]
18 Jul 2018, 11:23 am
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
21 Jun 2023, 9:01 pm
Teva Pharmaceuticals USA, Inc. [read post]
20 Jun 2023, 7:37 pm
Teva Pharmaceuticals USA, Inc. [read post]
15 Aug 2014, 7:08 am
Teva Pharmaceuticals USA, Inc. et al, 1-12-cv-08060 (NYSD August 13, 2014, Order) (Griesa, J.) [read post]
25 Mar 2017, 4:00 am
In 2010, the Whiteners sued PLIVA, Inc., Barr Laboratories, Inc., Teva Pharmaceutical Industries, Ltd., Alaven Pharmaceutical L.L.C., Meda Pharmaceuticals, Inc., and Schwarz Pharma, Inc. [read post]
23 Aug 2022, 8:52 pm
Lee (2016)"; and "Teva Pharmaceuticals USA, Inc. v. [read post]
2 Nov 2023, 8:32 pm
Related StoriesFDA Approves Sandoz Biosimilar for Tysabri®Solicitor General Files Brief Advocating Certiorari Grant in Teva Pharmaceuticals v. [read post]
26 Aug 2018, 4:35 am
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
10 May 2019, 11:15 am
This week in Other Barks & Bites, IPWatchdog's IP news roundup: the House of Representatives passes drug patent legislation, while antitrust legislation targeting patent-related activities is introduced into the Senate and the Trump administration mandates pricing information for pharmaceutical ads; the Patent Trial and Appeal Board (PTAB) issues a pair of precedential decisions on cases with multiple petitions; the USPTO issues marijuana-related trademark guidelines and a notice… [read post]
7 Mar 2024, 7:42 pm
The first of these is simlandi (adalimumab-ryvk), approved on February 24th, made by Alvotech and Teva Pharmaceuticals, and interchangeable with Humira). [read post]
7 Nov 2021, 9:31 am
The defendants included Johnson & Johnson, Teva Pharmaceutical Industries, Endo International and AbbVie Inc. [read post]
29 Jan 2013, 9:21 pm
By Micheal Greenfield -- Those of you who dabble with chemical structures while prosecuting or litigating pharmaceutical patents may find Allergan v. [read post]
8 Feb 2013, 11:04 am
Teva Pharmaceuticals USA, Inc., et. al., 1-10-cv-01796 (NYSD February 6, 2013, Order) (Sullivan, J.). [read post]
18 Sep 2021, 8:38 pm
Teva: Awaiting the Fate of Section VIII Carve-outs • The Current State of Patent Eligibility Jurisprudence: Redefining What Is Patent-Eligible Subject Matter... [read post]
14 Oct 2019, 2:15 pm
The finding of nonobviousness means that Actavis, owned by generic drug maker Teva Pharmaceuticals, is enjoined from engaging in the commercial use, offer for sale, or sale of its product covered in its Abbreviated New Drug Application (ANDA) until the expiration of U.S. [read post]
